Opportunity Information: Apply for RFA AT 19 003
The National Institutes of Health (NIH) funding opportunity RFA AT 19 003 invites applications to create a National Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO) under a U41 cooperative agreement mechanism, with clinical trials not allowed. The central goal is to build a national resource focused on upgrading and standardizing the technologies and methods used in natural products research, particularly in ways that remove current bottlenecks and raise the overall speed, rigor, and reproducibility of the field. In practical terms, the center is expected to develop, refine, adapt, and broadly disseminate cutting-edge approaches that make it easier to characterize natural products and understand what they do biologically, with a strong emphasis on improving chemical and biological annotation (for example, better identification, structure determination, and functional interpretation of complex natural product mixtures and constituents).
A defining feature of this FOA is that it is positioned as part of a coordinated set of NIH investments in natural products and botanical research infrastructure. It was released alongside the NCCIH NMR Open Access Data Exchange (NODE) effort and the Office of Dietary Supplements (ODS) Botanical Dietary Supplement Research Centers Program. Together, these related awards are described as the NCCIH/ODS Centers Advancing Research on Botanical and Other Natural Products (CARBON) Program. This signals that NP-TEMPO is not meant to operate in isolation; instead, it is intended to plug into a broader ecosystem of complementary NIH-supported resources, data-sharing efforts, and research centers to accelerate progress across the community.
Collaboration is explicitly encouraged through NP-TEMPO Technology Demonstration Projects (TDPs). These demonstration projects are meant to be a practical bridge between tool-building and real-world use, where NP-TEMPO works with NODE, the Botanical Dietary Supplement Research Centers, and other NCCIH, ODS, and NIH-funded groups to test and showcase new or improved technologies. The expectation is that the center will not only invent or optimize methods, but also prove their value in real research settings and help other groups adopt them, thereby increasing the productivity and impact of natural products research nationally.
The opportunity uses a cooperative agreement (U41), which generally indicates substantial NIH involvement during the project compared to a standard grant. While the specific management details are not provided in your excerpt, applicants should typically expect a more collaborative relationship with NIH program staff, including shared priorities around deliverables, coordination with related NIH initiatives, and community-facing outputs that can be broadly used by other researchers. The FOA is also clearly limited to non-clinical trial activities, keeping the focus on technology, methodology, and research-enabling infrastructure rather than clinical testing.
Eligibility is broad and includes many types of U.S.-based organizations and government entities, including state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); small businesses; public housing authorities/Indian housing authorities; and Native American tribal governments (federally recognized) as well as tribal organizations that are not federally recognized. The FOA also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
At the same time, there are important limits on foreign involvement. Non-domestic (non-U.S.) entities and non-domestic institutions are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components, as defined by the NIH Grants Policy Statement, are allowed. This typically means a U.S. applicant may include certain well-justified international collaborations or activities as foreign components under NIH policy, even though the applicant organization itself must be domestic and the project cannot be led by a foreign institution.
From the administrative details provided, the sponsoring agency is NIH, the opportunity category is discretionary, and the funding activity is within the health domain (CFDA numbers 93.213 and 93.321). The FOA was created on January 22, 2019, with an original closing date of April 29, 2019. The listed award ceiling is $700,000, indicating an upper bound on funding per award within the parameters of this announcement (the excerpt does not specify the project period or whether the ceiling is annual or total, so applicants would normally confirm that in the full FOA text).
Overall, NP-TEMPO is essentially a national-scale methods and technology center designed to modernize natural products research. It aims to raise the field's capabilities in identifying and interpreting natural product chemistry and biology, and it is structured to work hand-in-hand with NIH-supported data exchange and botanical research center efforts under the CARBON Program umbrella, using demonstration projects to ensure the tools developed are validated, adoptable, and broadly useful to the research community.Apply for RFA AT 19 003
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO) (U41 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.321.
- This funding opportunity was created on 2019-01-22.
- Applicants must submit their applications by 2019-04-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $700,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH RFA AT 19 003 - National Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO)
What is this funding opportunity?
This NIH funding opportunity (RFA AT 19 003) invites applications to establish a National Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO). The award is a U41 cooperative agreement, and clinical trials are not allowed.
What is the main goal of NP-TEMPO?
The center is intended to be a national resource that upgrades and standardizes technologies and methods used in natural products research. The goal is to reduce bottlenecks and improve the overall speed, rigor, and reproducibility of the field.
What types of work is the center expected to do?
NP-TEMPO is expected to develop, refine, adapt, and broadly disseminate advanced approaches that make it easier to characterize natural products and understand their biological effects. A major emphasis is improving chemical and biological annotation, such as stronger identification, structure determination, and functional interpretation of complex mixtures and their constituents.
What does "technology, methodology, and productivity optimization" mean in practice?
Based on the description provided, it means creating and improving research-enabling tools and standardized methods that help researchers more efficiently and reliably analyze natural products and link chemical features to biological meaning, especially when dealing with complex natural product mixtures.
Are clinical trials allowed under this opportunity?
No. The opportunity explicitly states that clinical trials are not allowed, keeping the focus on technology and methods rather than clinical testing.
What funding mechanism is used, and why does it matter?
The award uses a U41 cooperative agreement mechanism. In general, a cooperative agreement implies substantial NIH involvement compared to a standard grant, with an expectation of a more collaborative relationship with NIH program staff and shared focus on deliverables and coordination.
How is NP-TEMPO expected to interact with other NIH investments?
NP-TEMPO is positioned as part of a coordinated set of NIH investments in natural products and botanical research infrastructure. It is meant to connect with complementary NIH-supported resources and data-sharing efforts rather than operate in isolation.
What is the CARBON Program, and how does NP-TEMPO relate to it?
NP-TEMPO is described as part of the NCCIH/ODS Centers Advancing Research on Botanical and Other Natural Products (CARBON) Program. The FOA was released alongside the NCCIH NMR Open Access Data Exchange (NODE) effort and the Office of Dietary Supplements (ODS) Botanical Dietary Supplement Research Centers Program, signaling coordinated activities across these related awards.
What are NP-TEMPO Technology Demonstration Projects (TDPs)?
Technology Demonstration Projects (TDPs) are collaboration-focused projects intended to bridge tool-building with real-world use. They are meant to test and showcase new or improved technologies in practical research settings and to support adoption by other groups.
Who are the expected collaborators for Technology Demonstration Projects?
The FOA encourages NP-TEMPO to work with the NODE effort, the Botanical Dietary Supplement Research Centers, and other NCCIH-, ODS-, and NIH-funded groups to validate and demonstrate new or improved technologies.
What kinds of outputs are implied for the center?
The center is expected to produce community-facing, broadly disseminated technologies and methods, and to demonstrate their value through collaboration-focused projects so other researchers can adopt them and improve national research productivity.
Who is eligible to apply?
Eligibility is broad for U.S.-based organizations and government entities, including state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits (501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); small businesses; public housing authorities/Indian housing authorities; Native American tribal governments (federally recognized); and tribal organizations that are not federally recognized.
Are minority-serving institutions and community-based organizations eligible?
Yes. The FOA highlights additional eligible categories including Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); and faith-based or community-based organizations.
Are U.S. territories or possessions eligible?
Yes. The FOA notes eligibility that includes U.S. territories or possessions.
Can non-U.S. (foreign) organizations apply as the main applicant?
No. Non-domestic (non-U.S.) entities and non-domestic institutions are not eligible to apply.
Can a U.S. organization include a non-domestic component?
No. Non-domestic components of U.S. organizations are also not eligible to apply under this opportunity.
Are any types of foreign involvement allowed at all?
Yes. Foreign components, as defined by the NIH Grants Policy Statement, are allowed. This typically means a U.S. applicant may include certain well-justified international collaborations or activities as foreign components under NIH policy, even though the applicant organization itself must be domestic.
What agency is sponsoring this opportunity?
The sponsoring agency is the National Institutes of Health (NIH).
What is the opportunity category and domain?
The opportunity category is discretionary, and the funding activity is within the health domain.
What CFDA numbers are associated with this opportunity?
The CFDA numbers listed are 93.213 and 93.321.
What is the maximum award amount mentioned?
The listed award ceiling is $700,000. The excerpt does not specify whether this ceiling is per year or total, so applicants would typically confirm the details in the full FOA text.
When was the FOA created and when did it close?
The FOA was created on January 22, 2019, and the original closing date listed is April 29, 2019.
What is the overall purpose of NP-TEMPO in the natural products research landscape?
NP-TEMPO is described as a national-scale methods and technology center designed to modernize natural products research by improving capabilities for identifying and interpreting natural product chemistry and biology. It is structured to work closely with NIH-supported data exchange and botanical research center efforts under the CARBON Program umbrella, using demonstration projects to validate and promote adoption of the tools developed.
Browse more opportunities from the same category: Health
Next opportunity: Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required)
Previous opportunity: Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AT 19 003
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AT 19 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Botanical Dietary Supplements Research Centers (U19 Clinical Trial Optional) Apply for RFA OD 19 001 Funding Number: RFA OD 19 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,200,000 |
| Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed) Apply for RFA AT 19 002 Funding Number: RFA AT 19 002 Agency: National Institutes of Health Category: Health Funding Amount: $900,000 |
| Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional) Apply for PA 19 166 Funding Number: PA 19 166 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Development and Validation of Advanced Mammalian Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed) Apply for PAR 19 167 Funding Number: PAR 19 167 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanistic studies on chronic alcohol use and sleep homeostasis (R01 Clinical Trial Optional) Apply for RFA AA 19 006 Funding Number: RFA AA 19 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed) Apply for PAR 19 170 Funding Number: PAR 19 170 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) Apply for RFA HL 20 011 Funding Number: RFA HL 20 011 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) Apply for RFA HL 20 012 Funding Number: RFA HL 20 012 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) Apply for PAR 19 171 Funding Number: PAR 19 171 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed) Apply for PAR 19 173 Funding Number: PAR 19 173 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed) Apply for PAR 19 172 Funding Number: PAR 19 172 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 19 178 Funding Number: PAR 19 178 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development for Cryogenic or Other Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R21 Clinical Trial Not Allowed) Apply for PAR 19 176 Funding Number: PAR 19 176 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Human Three-Dimensional Cell Model Systems for Alzheimers Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA NS 19 027 Funding Number: RFA NS 19 027 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional) Apply for RFA MH 20 202 Funding Number: RFA MH 20 202 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional) Apply for RFA MH 20 200 Funding Number: RFA MH 20 200 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Local Organizations Network Project (LON) Apply for 7200AA19APS00001 Funding Number: 7200AA19APS00001 Agency: Agency for International Development Category: Health Funding Amount: $300,000,000 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional) Apply for RFA MH 20 201 Funding Number: RFA MH 20 201 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 19 179 Funding Number: PAR 19 179 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computational Models of Immunity (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 011 Funding Number: RFA AI 19 011 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 19 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
